Puretech Health Share Discussion Threads

[edwardt] 15/12/2017 18:12

I promise it is not all me! Amazed so little activity on this B.B.: this is probably the most exciting company I own by a country mike

[lendmeafiver] 15/12/2017 17:59

And 75,000, some serious accumulation this week

[lendmeafiver] 15/12/2017 14:44

Followed by 50,000 today

[lendmeafiver] 14/12/2017 09:50

Is that 37,000 at 1.48 paid late yesterday, this will breach 1.5 imminently in my view

[lendmeafiver] 13/12/2017 14:40

Bit of positive newsflow on wound induced hair regrowth, if Follica’s RAIN product works, perhaps in a similar way, then we have something potentially very valuable on ours hands here:

www.koreaherald.com/view.php?ud=20171121000807

[lendmeafiver] 13/12/2017 12:05

Bit of buying activity again, looking good

[lendmeafiver] 12/12/2017 16:21

Nice tick up here this afternoon

[edwardt] 06/12/2017 08:11

just shows insider buying should not be ignored. also pleased that steve davis at Jupiter has topped up to go over 5%. got to laugh that this is probably the only biotech incubator that woodford has not backed. i hope that is a good sign!

[lendmeafiver] 05/12/2017 10:10

Agree, going to get interesting next year, Bharatt Chowrira was accumulating whilst he was able to for a very good reason.

[edwardt] 05/12/2017 10:05

looks like ipos might well happen as well for two of the businesses - bring on 18 in my opinion.

[lendmeafiver] 04/12/2017 18:15

Just looking at the last report, many things in the pipeline over the coming months, I note even Follica get a mention, some encouraging signs in the below, is a hair loss cure here too good to be true?:

Additional progress has also been made toward the initiation of the Follica RAIN pivotal study in androgenetic alopecia as well as the identification and testing of next-generation, proprietary compounds based on the Group’s intellectual property. The Follica RAIN pivotal study is expected to commence in the first half of 2018, following the completion of an optimisation study that is expected to begin imminently. The Follica RAIN platform builds on new insights into cell signalling and leverages immune pathways activated during wound healing to create new hair follicles and hair in adult skin.

[edwardt] 04/12/2017 11:07

liberum contend this is trading on a 50% discount to nav. always a spurious measure but two good developments in a week should see this at 150p imo.

[lendmeafiver] 04/12/2017 09:28

Yes very good news today, the company IR will assist I’m sure.

[edwardt] 04/12/2017 08:44

ditto - bit annoying. anyway great news out today...

[lendmeafiver] 03/12/2017 19:58

No I didn’t, neither is the presentation on the website, well I can’t find it if it is.

[edwardt] 16/11/2017 15:21

anyone listen in today? it does not appear to be on website yet for playback...

[edwardt] 12/10/2017 15:38

nice to know. would love this to be a billion £ company in 3 years. here's hoping!

[macarre] 12/10/2017 08:01

PRTC mentioned in Jim Mellon's new book 'Juvenescence'. One of the shares that would be in his biotech portfolio. Not sure he holds any but imagine he does.

[rambutan2] 29/9/2017 09:22

Hopefully Akili's trial results will leave less room for doubt:

[edwardt] 04/9/2017 11:16

also motley fool said similar to ic.

[poppa wobbler] 04/9/2017 07:36

Good to see Bharatt Chowrira continuing to fill his boots at 139p.

[rambutan2] 02/9/2017 18:25

Gets a results write up in IC, bit too cheap they say and give it a Buy.

[rambutan2] 02/9/2017 13:51

Yes, lots happening, cash ok for at least another year, and Gelesis and Akili trial results nearing. If the former can kick us off with a positive then that would be perfect. If not, well a few weeks to lick our wounds and then hopefully Akili will save the day...